Mimio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 11

Mimio General Information

Description

Developer of a biomimetic longevity supplement designed to enhance cellular health. The company's product utilizes clinically-validated fasting metabolites and biomimetic technology to provide autophagy activation, mitochondrial repair and metabolic regulation, enabling health-conscious consumers to achieve the benefits of prolonged fasting and reduce biological age through a daily nutritional interface.

Contact Information

Website
www.mimiohealth.com
Formerly Known As
Panacea Longevity, Innate Biology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 95, 3rd Street
  • San Francisco, CA 94103
  • United States
+1 (833)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Consumer Non-Durables
Vertical(s)
LOHAS & Wellness, E-Commerce, Life Sciences
Corporate Office
  • 95, 3rd Street
  • San Francisco, CA 94103
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mimio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 20-Mar-2023 $2.5M Completed Generating Revenue
3. Seed Round 19-Jul-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Feb-2021 $500K $500K Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Generating Revenue
To view Mimio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Mimio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mimio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
10X Capital Venture Capital Minority
AgFunder Venture Capital Minority
Better Ventures Venture Capital Minority
Gaingels Venture Capital Minority
R42 Group Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Mimio FAQs

  • When was Mimio founded?

    Mimio was founded in 2020.

  • Where is Mimio headquartered?

    Mimio is headquartered in San Francisco, CA.

  • What is the size of Mimio?

    Mimio has 4 total employees.

  • What industry is Mimio in?

    Mimio’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Mimio a private or public company?

    Mimio is a Private company.

  • What is Mimio’s current revenue?

    The current revenue for Mimio is .

  • How much funding has Mimio raised over time?

    Mimio has raised $3M.

  • Who are Mimio’s investors?

    10X Capital, AgFunder, Better Ventures, Gaingels, and R42 Group are 5 of 11 investors who have invested in Mimio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process